Laskowska M - Search Results

1

Lead Levels in Non-Occupationally Exposed Women with Preeclampsia.

Gajewska K, Laskowska M, Almeida A, Pinto E, Skórzyńska-Dziduszko K, Błażewicz A. Gajewska K, et al. Among authors: laskowska m. Molecules. 2021 May 20;26(10):3051. doi: 10.3390/molecules26103051. Molecules. 2021. PMID: 34065439 Free PMC article.

2

Phase equilibria study of the binary systems (1-butyl-3-methylimidazolium thiocyanate ionic liquid + organic solvent or water).

Domańska U, Laskowska M, Pobudkowska A. Domańska U, et al. Among authors: laskowska m. J Phys Chem B. 2009 May 7;113(18):6397-404. doi: 10.1021/jp900990s. J Phys Chem B. 2009. PMID: 19402727

3

Comparative analysis of the maternal and umbilical interleukin-8 levels in normal pregnancies and in pregnancies complicated by preeclampsia with intrauterine normal growth and intrauterine growth retardation.

Laskowska M, Laskowska K, Leszczyńska-Gorzelak B, Oleszczuk J. Laskowska M, et al. Among authors: laskowska k. J Matern Fetal Neonatal Med. 2007 Jul;20(7):527-32. doi: 10.1080/14767050701412719. J Matern Fetal Neonatal Med. 2007. PMID: 17674266

4

Evaluation of sCD30 level in maternal serum in pregnancies complicated by severe preeclampsia.

Laskowska M, Laskowska K, Oleszczuk J. Laskowska M, et al. Among authors: laskowska k. Med Wieku Rozwoj. 2011 Jan-Mar;15(1):73-8. Med Wieku Rozwoj. 2011. PMID: 21786515

5

Differences in the association between maternal serum homocysteine and ADMA levels in women with pregnancies complicated by preeclampsia and/or intrauterine growth restriction.

Laskowska M, Laskowska K, Oleszczuk J. Laskowska M, et al. Among authors: laskowska k. Hypertens Pregnancy. 2013;32(1):83-93. doi: 10.3109/10641955.2012.751993. Epub 2012 Dec 28. Hypertens Pregnancy. 2013. PMID: 23273067

6

The relation of maternal serum eNOS, NOSTRIN and ADMA levels with aetiopathogenesis of preeclampsia and/or intrauterine fetal growth restriction.

Laskowska M, Laskowska K, Oleszczuk J. Laskowska M, et al. Among authors: laskowska k. J Matern Fetal Neonatal Med. 2015 Jan;28(1):26-32. doi: 10.3109/14767058.2014.900036. Epub 2014 Apr 9. J Matern Fetal Neonatal Med. 2015. PMID: 24588201

7

Altered Maternal Serum Matrix Metalloproteinases MMP-2, MMP-3, MMP-9, and MMP-13 in Severe Early- and Late-Onset Preeclampsia.

Laskowska M. Laskowska M. Biomed Res Int. 2017;2017:6432426. doi: 10.1155/2017/6432426. Epub 2017 Jul 17. Biomed Res Int. 2017. PMID: 28798935 Free PMC article. Clinical Trial.

8

Preeclampsia - Current Management and Future Approach.

Dymara-Konopka W, Laskowska M, Oleszczuk J. Dymara-Konopka W, et al. Among authors: laskowska m. Curr Pharm Biotechnol. 2018;19(10):786-796. doi: 10.2174/1389201019666180925120109. Curr Pharm Biotechnol. 2018. PMID: 30255751 Review.

9

Angiogenic Imbalance as a Contributor of Preeclampsia.

Dymara-Konopka W, Laskowska M, Błażewicz A. Dymara-Konopka W, et al. Among authors: laskowska m. Curr Pharm Biotechnol. 2018;19(10):797-815. doi: 10.2174/1389201019666180925115559. Curr Pharm Biotechnol. 2018. PMID: 30255753 Review.

10

Preeclampsia - Aetiopathogenesis and Clinical Management.

Laskowska M. Laskowska M. Curr Pharm Biotechnol. 2018;19(10):762-763. doi: 10.2174/138920101910181112114656. Curr Pharm Biotechnol. 2018. PMID: 30598064

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

90 results

Search Page